Evidence map›Paper›PMID 41212263›Full record

ArticleBasic research in cardiology2025

Correction: IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of ischemic preconditioning.

Sauri Hernandez-Resendiz, Reinis Vilskersts, David Aluja, Ioanna Andreadou, Péter Bencsik, Maija Dambrova, Panagiotis Efentakis, Fei Gao, Zoltán Giricz, Gábor B Brenner and 21 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Basic research in cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Sauri Hernandez-ResendizCardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, 8 College Road, Singapore, Singapore.
Reinis VilskerstsLaboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Riga, Latvia.
David AlujaVall d'hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Ioanna AndreadouLaboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Péter BencsikDepartment of Pharmacology and Pharmacotherapy, Albert-Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Maija DambrovaLaboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Riga, Latvia.
Panagiotis EfentakisLaboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Fei GaoNational Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.
Zoltán GiriczPharmahungary Group, Szeged, Hungary.
Gábor B BrennerPharmahungary Group, Szeged, Hungary.
Nabil V SayourPharmahungary Group, Szeged, Hungary.
Tamás G GergelyPharmahungary Group, Szeged, Hungary.
András MakkosPharmahungary Group, Szeged, Hungary.
Javier InserteVall d'hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Roisin Kelly-LaubscherDepartment of Pharmacology and Therapeutics, School of Medicine, College of Medicine and Health, University College Cork, Cork, Ireland.
Attila KissLudwig Boltzmann Institute for Cardiovascular Research at Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria.
Thomas KriegDepartment of Medicine, University of Cambridge, Cambridge, UK.
Brenda R KwakDepartment of Pathology and Immunology, and Geneva Center for Inflammation Research, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Sandrine LecourCape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Gary LopaschukCardiovascular Research Centre, University of Alberta, Edmonton, Canada.
Michał MączewskiDepartment of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Michał WaszkiewiczDepartment of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Marta OknińskaDepartment of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Pasquale PagliaroClinical and Biological Science Department, University of Turin, Turin, Italy.
Bruno PodesserLudwig Boltzmann Institute for Cardiovascular Research at Center for Biomedical Research and Translational Surgery, Medical University of Vienna, Vienna, Austria.
Hiran A PragDepartment of Medicine, University of Cambridge, Cambridge, UK.
Marisol Ruiz-MeanaVall d'hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Tamara SzabadosDepartment of Pharmacology and Pharmacotherapy, Albert-Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Coert J ZuurbierAmsterdam UMC, Location AMC, Department of Anaesthesiology, Laboratory of Experimental Intensive Care and Anaesthesiology (L.E.I.C.A.), Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
Péter FerdinandyMTA‑se System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Nagyvárad Tér 4, Budapest, 1089, Hungary. peter.ferdinandy@pharmahungary.com.
Derek J HausenloyCardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School, 8 College Road, Singapore, Singapore. derek.hausenloy@duke-nus.edu.sg.ORCID http://orcid.org/0000-0003-0729-4956

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41212263
PMCPMC12680880

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.